Skip to main content

Published locations for ACR: Sulfasalazine reduces TNFi antibodies but more poorly than methotrexate

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ACR: Sulfasalazine reduces TNFi antibodies but more poorly than methotrexate

User login

  • Reset your password
  • /content/acr-sulfasalazine-reduces-tnfi-antibodies-more-poorly-methotrexate
  • /familypracticenews/article/105681/spondyloarthropathies/acr-sulfasalazine-reduces-tnfi-antibodies
  • /internalmedicinenews/article/105681/spondyloarthropathies/acr-sulfasalazine-reduces-tnfi-antibodies
  • /rheumatologynews/article/105681/spondyloarthropathies/acr-sulfasalazine-reduces-tnfi-antibodies-more
  • /rheumatology/article/105681/spondyloarthropathies/acr-sulfasalazine-reduces-tnfi-antibodies-more
  • /internalmedicine/article/105681/spondyloarthropathies/acr-sulfasalazine-reduces-tnfi-antibodies-more
  • /familymedicine/article/105681/spondyloarthropathies/acr-sulfasalazine-reduces-tnfi-antibodies-more